Show simple item record

dc.contributor.authorLu, S-C
dc.contributor.authorPorter, I
dc.contributor.authorValderas, JM
dc.contributor.authorHarrison, CJ
dc.contributor.authorSidey-Gibbons, C
dc.date.accessioned2024-07-22T09:59:28Z
dc.date.issued2023-06-05
dc.date.updated2024-07-18T12:27:32Z
dc.description.abstractBACKGROUND: Research shows that feeding back patient-reported outcome information to clinicians and/or patients could be associated with improved care processes and patient outcomes. Quantitative syntheses of intervention effects on oncology patient outcomes are lacking. OBJECTIVE: To determine the effects of patient-reported outcome measure (PROM) feedback intervention on oncology patient outcomes. DATA SOURCES: We identified relevant studies from 116 references included in our previous Cochrane review assessing the intervention for the general population. In May 2022, we conducted a systematic search in five bibliography databases using predefined keywords for additional studies published after the Cochrane review. STUDY SELECTION: We included randomized controlled trials evaluating the effects of PROM feedback intervention on processes and outcomes of care for oncology patients. DATA EXTRACTION AND SYNTHESIS: We used the meta-analytic approach to synthesize across studies measuring the same outcomes. We estimated pooled effects of the intervention on outcomes using Cohen's d for continuous data and risk ratio (RR) with a 95% confidence interval for dichotomous data. We used a descriptive approach to summarize studies which reported insufficient data for a meta-analysis. MAIN OUTCOME(S) AND MEASURES(S): Health-related quality of life (HRQL), symptoms, patient-healthcare provider communication, number of visits and hospitalizations, number of adverse events, and overall survival. RESULTS: We included 29 studies involving 7071 cancer participants. A small number of studies was available for each metanalysis (median = 3 studies, ranging from 2 to 9 studies) due to heterogeneity in the evaluation of the trials. We found that the intervention improved HRQL (Cohen's d = 0.23, 95% CI 0.11-0.34), mental functioning (Cohen's d = 0.14, 95% CI 0.02-0.26), patient-healthcare provider communication (Cohen's d = 0.41, 95% CI 0.20-0.62), and 1-year overall survival (OR = 0.64, 95% CI 0.48-0.86). The risk of bias across studies was considerable in the domains of allocation concealment, blinding, and intervention contamination. CONCLUSIONS AND RELEVANCE: Although we found evidence to support the intervention for highly relevant outcomes, our conclusions are tempered by the high risk of bias relating mainly to intervention design. PROM feedback for oncology patients may improve processes and outcomes for cancer patients but more high-quality evidence is required.en_GB
dc.description.sponsorshipDivision of Internal Medicine Immuno‐Oncology Toxicity Award Program, University of Texas MD Anderson Cancer Centeren_GB
dc.format.extent54-
dc.format.mediumElectronic
dc.identifier.citationVol. 7(1), article 54en_GB
dc.identifier.doihttps://doi.org/10.1186/s41687-023-00578-8
dc.identifier.urihttp://hdl.handle.net/10871/136803
dc.identifierORCID: 0000-0002-2440-8727 (Porter, I)
dc.identifierORCID: 0000-0002-9299-1555 (Valderas, JM)
dc.language.isoenen_GB
dc.publisherSpringeren_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37277575en_GB
dc.rights© The Author(s) 2023. Open Access.This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_GB
dc.subjectCancer careen_GB
dc.subjectPatient-centered careen_GB
dc.subjectPatient-reported outcome measureen_GB
dc.subjectSystematic review and meta-analysisen_GB
dc.titleEffectiveness of routine provision of feedback from patient-reported outcome measurements for cancer care improvement: a systematic review and meta-analysisen_GB
dc.typeArticleen_GB
dc.date.available2024-07-22T09:59:28Z
dc.identifier.issn2509-8020
exeter.article-number54
exeter.place-of-publicationGermany
dc.descriptionThis is the final version. Available on open access from Springer via the DOI in this recorden_GB
dc.descriptionAvailability of data and materials: All data generated or analyzed during this study are included in this published article and its Additional files.en_GB
dc.identifier.eissn2509-8020
dc.identifier.journalJournal of Patient-Reported Outcomesen_GB
dc.relation.ispartofJ Patient Rep Outcomes, 7(1)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-03-22
dc.rights.licenseCC BY
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-06-05
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-07-22T09:57:43Z
refterms.versionFCDVoR
refterms.dateFOA2025-03-07T00:52:56Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-06-05


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2023. Open Access.This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © The Author(s) 2023. Open Access.This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.